Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is a randomized clinical phase II treatment trial studying PRIM-DJ2727 (low vs mid vs high dosage) in patients suffering from Clostridioides difficile infection (CDI) (recurrent)
Safety
Terminated, investigators are no longer considering FMT product development for C. difficile
…